DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,194 filers reported holding DANAHER CORPORATION in Q4 2017. The put-call ratio across all filers is 0.78 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,777,102 | -4.6% | 7,163 | -7.7% | 0.27% | +0.7% |
| Q2 2023 | $1,861,856 | -10.8% | 7,758 | -6.4% | 0.27% | -17.5% |
| Q1 2023 | $2,088,284 | -4.2% | 8,286 | +0.9% | 0.33% | -7.9% |
| Q4 2022 | $2,179,976 | +5.3% | 8,213 | +2.4% | 0.35% | -5.6% |
| Q3 2022 | $2,071,000 | +14.8% | 8,019 | +12.7% | 0.38% | +19.4% |
| Q2 2022 | $1,804,000 | -12.2% | 7,114 | +1.6% | 0.31% | +2.3% |
| Q1 2022 | $2,054,000 | -7.6% | 7,001 | +3.6% | 0.31% | +1.3% |
| Q4 2021 | $2,224,000 | -6.4% | 6,760 | -13.4% | 0.30% | -16.1% |
| Q3 2021 | $2,376,000 | +8.8% | 7,806 | -4.1% | 0.36% | +8.4% |
| Q2 2021 | $2,183,000 | +20.2% | 8,136 | +0.9% | 0.33% | +14.8% |
| Q1 2021 | $1,816,000 | +0.4% | 8,067 | -0.9% | 0.29% | -6.5% |
| Q4 2020 | $1,808,000 | -22.3% | 8,141 | -24.6% | 0.31% | -30.6% |
| Q3 2020 | $2,326,000 | +20.3% | 10,802 | -1.2% | 0.45% | +6.7% |
| Q2 2020 | $1,934,000 | +123.6% | 10,935 | +74.9% | 0.42% | +67.6% |
| Q1 2020 | $865,000 | -28.7% | 6,253 | -20.9% | 0.25% | +1.6% |
| Q4 2019 | $1,213,000 | +32.1% | 7,906 | +24.3% | 0.25% | +22.4% |
| Q3 2019 | $918,000 | -10.6% | 6,359 | -11.5% | 0.20% | -12.6% |
| Q2 2019 | $1,027,000 | +3.9% | 7,188 | -3.9% | 0.23% | -0.4% |
| Q1 2019 | $988,000 | +44.4% | 7,481 | +12.9% | 0.23% | +23.5% |
| Q4 2018 | $684,000 | -8.2% | 6,629 | -3.3% | 0.19% | +13.3% |
| Q3 2018 | $745,000 | +4.5% | 6,858 | -5.1% | 0.16% | -1.2% |
| Q2 2018 | $713,000 | -7.3% | 7,225 | -8.0% | 0.17% | -10.7% |
| Q1 2018 | $769,000 | -1.2% | 7,855 | -6.2% | 0.19% | +1.6% |
| Q4 2017 | $778,000 | +5.7% | 8,378 | -2.4% | 0.18% | -1.1% |
| Q3 2017 | $736,000 | -4.8% | 8,583 | -6.4% | 0.19% | -7.9% |
| Q2 2017 | $773,000 | +2.2% | 9,165 | +3.7% | 0.20% | +0.5% |
| Q1 2017 | $756,000 | +19.6% | 8,836 | +8.9% | 0.20% | +10.4% |
| Q4 2016 | $632,000 | +10.9% | 8,115 | +11.5% | 0.18% | +9.0% |
| Q3 2016 | $570,000 | -29.9% | 7,275 | -9.7% | 0.17% | -32.7% |
| Q2 2016 | $813,000 | – | 8,054 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 345,428 | $39,965,000 | 17.38% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 276,826 | $36,547,000 | 13.04% |
| Eos Focused Equity Management, L.P. | 58,266 | $7,692,000 | 9.98% |
| Bodenholm Capital AB | 204,595 | $27,011,000 | 9.90% |
| CORTLAND ASSOCIATES INC/MO | 446,012 | $58,883,000 | 9.52% |
| MIROVA | 128,368 | $16,947,000 | 9.18% |
| Flossbach von Storch AG Zurich | 50,275 | $6,637,000 | 8.09% |
| Ostrum Asset Management U.S., LLC | 211,464 | $27,917,000 | 7.77% |
| Circle Road Advisors LP | 45,446 | $6,000,000 | 6.49% |
| Eversept Partners, LP | 158,764 | $20,985,459 | 6.12% |